Table 5.
Clinical Outcome at Final Follow-up: Lesion Location.
| Location |
||||
|---|---|---|---|---|
| MACI Group |
BMAC Group |
|||
| Scoresa | Patellar | Trochlear | Patellar | Trochlear |
| IKDC Subjective | 74.19 ± 6.32 | 84.12 ± 4.10 | 89.19 ± 2.23 | 89 ± 3.56 |
| IKDC Objective | 4A, 3B | 5A | 6A | 2A |
| KOOS Pain | 75.57 ± 9.43 | 93.6 ± 6.54 | 98.33 ± 2.65 | 98.5 ± 2.12 |
| KOOS Symptom | 76.71 ± 8.17 | 93.4 ± 4.77 | 94.16 ± 9.88 | 97 ± 4.24 |
| KOOS ADL | 78.28 ± 10.04 | 94.6 ± 5.81 | 97.50 ± 2.81 | 100 ± 0 |
| KOOS SRA | 59.14 ± 12.34 | 85 ± 8.60 | 87.5 ± 9.87 | 95 ± 0 |
| KOOS QOL | 63.14 ± 13.47 | 94 ± 6.51 | 91.16 ± 9.78 | 87.5 ± 10.60 |
| Tegner | 5.14 ± 1.34 | 6 ± 0.70 | 6 ± 0.63 | 7.5 ± 0.70 |
| VAS | 1 ± 0.57 | 0.2 ± 0.44 | 0.16 ± 0.40 | 0 ± 0 |
MACI = matrix-induced autologous chondrocyte implantation; BMAC = bone marrow aspirate concentrate; VAS = visual analog scale; IKDC = International Knee Documentation Committee; KOOS = Knee Injury Osteoarthritis Outcome Score; ADL = activities of daily living; SRA = sports and recreational activities; QOL = quality of life.
a
All scores are final follow-up scores with mean ± standard deviation values. The difference in improvement in the subgroups are nonsignificant (P = 0.999) in all scores, for both MACI and BMAC patients; exceptions are reported in text.